Original Article | Published:

Early versus 6–12 week postpartum glucose tolerance testing for women with gestational diabetes

Journal of Perinatology volume 38, pages 118121 (2018) | Download Citation

Abstract

Objective:

The objective of this study is to estimate the accuracy of early oral glucose tolerance testing (GTT), to predict impaired glucose tolerance.

Study Design:

This was a prospective cohort study. Women received an early 75 g 2 h GTT between postpartum days 2–4 and again 6–12 weeks postpartum. The ability of the early GTT to accurately detect impaired glucose tolerance and diabetes was assessed by calculating sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPVs). The routine 6–12-week postpartum GTT was considered the gold standard.

Results:

The early GTT was completed by 100% of subjects, whereas only 31 of 58 (53%) women returned to complete the 6–12-week postpartum GTT. The early GTT had modest sensitivity for impaired glucose tolerance (62.5%) and overt diabetes (50%). However, it had excellent specificity (100%), PPV (100%) and NPV (96.7%) for diabetes. The NPV for impaired glucose tolerance with the early GTT was 80%.

Conclusion:

Rates of 6–12 week postpartum GTT completion among patients with gestational diabetes is poor. Appropriate postpartum management may improve by using the early GTT as a screening test.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , . American diabetes A. Economic costs of diabetes in the US in 2002. Diabetes care 2003; 26(3): 917–932.

  2. 2.

    , , , , , . Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metabol 2010; 95(2): 670–677.

  3. 3.

    , , , , . Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care 2011; 34(7): 1582–1584.

  4. 4.

    Practice Bulletin No. 137. Gestational diabetes mellitus. Obstet Gynecol 2013; 122(2 Pt 1): 406–416.

  5. 5.

    World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. WHO Document Production Services: Geneva, Switzerland, 2006.

  6. 6.

    National Institute for Health and Clinical Excellence (NICE) National Collaborating Centre for Women’s and Children’s Health. Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the postnatal period. National Institute for Health and Clinical Excellence (NICE) National Collaborating Centre for Women’s and Children’s Health. RCOG Press: London, 2008.

  7. 7.

    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31(suppl. 1): S55–S60.

  8. 8.

    Committee on Obstetric Practice. ACOG committee opinion no. 435: postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009; 113(6): 1419–1421.

  9. 9.

    , , , , , et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160–3167.

  10. 10.

    , , , , , et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30(suppl. 2): S251–S260.

  11. 11.

    , , , , . How can we increase postpartum glucose screening in women at high risk for gestational diabetes mellitus? Int J Endocrinol 2012; 2012: 519267.

  12. 12.

    , , , . Physician care patterns and adherence to postpartum glucose testing after gestational diabetes mellitus in Oregon. PLoS ONE 2012; 7(10): e47052.

  13. 13.

    , , , , , et al. The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes? Chronic Dis Can 2011; 31(2): 58–64.

  14. 14.

    , , , . Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 2011; 8(6): A124.

  15. 15.

    , . Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 2011; 18(6): 409–416.

  16. 16.

    , , , , , et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 2016; 374(7): 647–655.

  17. 17.

    , , , , . Early postpartum glucose testing in women with gestational diabetes mellitus. Am J Perinatol 2016; 33(10): 966–971.

Download references

Acknowledgements

EBC was supported by a NIH T32 training grant (5T32HD055172-05). Support for this research was provided in part by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Author information

Affiliations

  1. Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA

    • E B Carter
    • , S Martin
    • , L A Temming
    • , G A Colditz
    • , G A Macones
    •  & M G Tuuli

Authors

  1. Search for E B Carter in:

  2. Search for S Martin in:

  3. Search for L A Temming in:

  4. Search for G A Colditz in:

  5. Search for G A Macones in:

  6. Search for M G Tuuli in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to E B Carter.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/jp.2017.159